Stockscreener 앱 받기
2.33
2.19%
0.05
전일 마감가:
$2.28
열려 있는:
$2.29
하루 거래량:
105.88K
Relative Volume:
0.37
시가총액:
$70.67M
수익:
$188.16M
순이익/손실:
$18.43M
주가수익비율:
5.1778
EPS:
0.45
순현금흐름:
$26.45M
1주 성능:
+7.37%
1개월 성능:
+2.64%
6개월 성능:
-9.69%
1년 성능:
-44.66%
1일 변동 폭
$2.25
$2.35
1주일 범위
$2.14
$2.35
52주 변동 폭
$1.27
$4.7498
Biote Corp Stock (BTMD) Company Profile
명칭
Biote Corp
전화
972-486-9346
주소
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.50 | 3.32B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.04 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.26 | 327.48M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.45 | 292.26M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.47 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-12-16 | 개시 | Craig Hallum | Buy |
| 2024-02-20 | 개시 | B. Riley Securities | Buy |
| 2024-02-01 | 개시 | Jefferies | Buy |
| 2022-06-24 | 개시 | Cowen | Outperform |
| 2022-06-23 | 개시 | ROTH Capital | Buy |
모두보기
Biote Corp 주식(BTMD)의 최신 뉴스
Tranche Update on biote Corp.'s Equity Buyback Plan announced on January 25, 2024. - marketscreener.com
Price to earnings forward of Biote Corp. – NASDAQ:BTMD - TradingView
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2000 Index - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Biote Corp.(NasdaqGM: BTMD) dropped from Russell 3000E Value Benchmark - marketscreener.com
biote Corp. Class A Actuals & Estimates (NASDAQ:BTMD) - TradingView
BTMD Forecast — Price Target — Prediction for 2027 - TradingView
BTMD Q1 2026 Earnings: EPS Beats Estimates by 23.7% Amidst Market SkepticismRevenue Recognition Risk - dars.gov.et
Biote Corp (BTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biote Corp. (BTMD) Holds Steady Near Support as Slight Decline PersistsIV Contraction - dars.gov.et
Biote Corp (BTMD) Institutional Confidence - TradingKey
Biote Corp (BTMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biote Corp (BTMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biote Corp (BTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biote Corp (BTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biote Corp (BTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biote Corp (BTMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biote Corp (BTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
biote (BTMD) details salary, bonus and equity for Interim CEO Peterson - Stock Titan
biote Corp. (BTMD) interim CEO receives 206,746 stock options at $2.46 strike - Stock Titan
Biote Corp. (BTMD) Slides 2.67% as Stock Tests Key Support LevelsSmart Beta Flow - dars.gov.et
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beats Estimates by 23.71%, Stock Edges HigherHigh Growth Earnings - newsline.com
biote Corp. (BTMD) director receives 130,000 stock options at $2.34 strike - Stock Titan
biote Corp. (BTMD) Executive Chairman receives 114,157 stock options at $2.34 - Stock Titan
Biote Corp. (BTMD) Holds Steady at $2.34: Consolidation or Calm Before the Next Move?Hot Stock Picks - newsline.com
Biote Corp. Q1 2026 Earnings: EPS Beat Drives Cautious Optimism Amidst Flat Revenue DisclosureLong-Term Guidance - newsline.com
How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations - Yahoo Finance
Biote Corp. (BTMD) Slides Toward Key Support Level as Selling Pressure PersistsFactor Rotation - newsline.com
Biote Appoints Bob Peterson as Interim CEO, Reaffirms 2026 Financial Guidance Amid Leadership Transition - Minichart
Biote (NASDAQ: BTMD) names interim CEO, appoints Executive Chairman and reaffirms 2026 outlook - Stock Titan
Biote appoints Bajaj as Chief Medical Officer - TipRanks
Biote Corp. (BTMD) Q1 2026 Earnings: EPS Beat Drives 4.5% Stock UptickEBITDA Analysis - The Legal Advocate
Biote names Komal Bajaj as chief medical officer - Investing.com
Biote names Komal Bajaj as chief medical officer By Investing.com - Investing.com South Africa
NYC hospital quality chief Komal Bajaj becomes Biote CMO - Stock Titan
Biote Corp. Q1 2026 Earnings: EPS Beats Estimates but Stock Declines Amid Revenue Uncertainty - newsline.com
BTMD Q1 2026 Earnings: EPS Surprises by 23.7% Despite Negative Stock ReactionStrong Earnings Momentum - newsline.com
CEO out after year leading hormone therapy company Biote - The Business Journals
Bob Peterson Named Interim CEO of Biote Corp., Effective May 28, 2026 - geneonline.com
Biote Names Its Chief Financial and Business Officer as Interim CEO - Dallas Innovates
Biote names CFO Bob Peterson as interim CEO, reaffirms FY26 outlook amid leadership shift - MSN
Biote announces Christensen to step down as CEO, Peterson named interim CEO - TipRanks
Biote names Bob Peterson interim CEO as Christensen steps down - Investing.com UK
Biote Announces Management Changes - marketscreener.com
Biote Announces Chief Executive Officer Changes - marketscreener.com
Biote Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
Biote names Bob Peterson as interim CEO - marketscreener.com
Biote Corp (BTMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
0.24%
자본화:
|
볼륨(24시간):